XML 55 R42.htm IDEA: XBRL DOCUMENT v3.26.1
Balance Sheet Components - Schedule of Accrued Expenses and Other Current Liabilities (Details) - USD ($)
$ in Thousands
Mar. 31, 2026
Dec. 31, 2025
Organization, Consolidation and Presentation of Financial Statements [Abstract]    
Accrued compensation $ 9,218 $ 32,179
Accrued clinical and other research & development costs 21,475 22,283
Accrued manufacturing costs 9,031 5,336
Operating lease liability, current 9,769 9,463
Finance lease liability, current 90 83
Deferred research and development funding liability, current 15,116 21,101
Other accrued costs and current liabilities 5,077 7,401
Total accrued expenses and other current liabilities $ 69,776 $ 97,846